Value-based purchasing is a payment model that ties healthcare reimbursement to the quality of care delivered rather than the quantity of services performed. Instead of paying hospitals and clinicians a set fee for every test, procedure, or office visit, value-based purchasing rewards providers who achieve better patient outcomes, fewer complications, and lower overall costs. The model represents a fundamental shift in how healthcare is financed in the United States, particularly within Medicare.
How It Differs From Fee-for-Service
The traditional fee-for-service model pays providers for each individual service they deliver. A hospital bills for every lab test, imaging scan, and day of admission. A physician bills for every office visit. The more services rendered, the more revenue generated. This creates a built-in incentive to do more, regardless of whether “more” leads to better health.
Value-based purchasing flips that incentive. Providers are rewarded for keeping patients healthy, avoiding preventable complications, and delivering efficient care. A hospital that reduces surgical infections or readmissions earns more under this model, even if it performs fewer billable procedures in the process. The core idea is straightforward: pay for results, not volume.
In practice, value-based payment spans a range of financial arrangements. Some programs offer bonuses on top of standard payments when quality targets are met (pay-for-performance). Others ask providers to share in the savings when costs come in below a benchmark (one-sided risk). The most aggressive models require providers to also absorb losses when costs exceed the target (two-sided risk).
Medicare’s Hospital VBP Program
The largest and most visible example is Medicare’s Hospital Value-Based Purchasing Program, run by the Centers for Medicare and Medicaid Services (CMS). This program evaluates hospitals on a set of performance measures and adjusts their Medicare payments accordingly. Hospitals that score well earn back more than they contributed, while lower-performing hospitals receive less.
CMS scores hospitals across several categories:
- Mortality and complications: rates of death and serious problems after treatment for conditions like heart attack, heart failure, and pneumonia
- Healthcare-associated infections: preventable infections patients acquire during a hospital stay
- Patient safety: measures of how reliably a hospital avoids errors and harm
- Patient experience: survey results reflecting how patients rated their communication with staff, pain management, and discharge planning
- Efficiency and cost reduction: how much Medicare spends per patient relative to what was expected
Each hospital receives a Total Performance Score based on these categories. That score determines whether the hospital’s Medicare payments are adjusted upward or downward.
How Patient Experience Surveys Factor In
One of the more surprising elements for many people is that patient surveys directly influence hospital payments. The HCAHPS survey (Hospital Consumer Assessment of Healthcare Providers and Systems) asks discharged patients about their experience: how well nurses and doctors communicated, how responsive staff were, how clean and quiet the hospital was, and whether they understood their discharge instructions.
CMS converts those survey results into a domain score ranging from 0 to 100 points. The score combines two components: a base score (up to 80 points) reflecting performance across eight survey dimensions, and a consistency score (up to 20 points) rewarding hospitals that perform well across all dimensions rather than excelling in some while lagging in others. Patient experience currently carries a weight of 25% in the overall Total Performance Score, making it a meaningful portion of the financial calculation.
How Individual Clinicians Are Affected
Value-based purchasing doesn’t stop at hospitals. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) created the Quality Payment Program, which applies value-based principles to individual physicians and other clinicians. MACRA replaced an older, widely criticized payment formula and created two tracks for clinicians to participate in.
The first track, the Merit-based Incentive Payment System (MIPS), consolidates several older quality reporting programs into a single framework. Clinicians are scored on quality measures, cost, how they use health information technology, and improvement activities. High scorers receive a payment bonus; low scorers face a payment reduction.
The second track offers bonus payments for clinicians who participate in Alternative Payment Models (APMs). These are more structured arrangements, like accountable care organizations, where groups of providers take collective responsibility for the cost and quality of care for a defined patient population. Clinicians in qualifying APMs are exempt from MIPS reporting and receive separate financial incentives.
Does It Actually Work?
The evidence on value-based purchasing is mixed but increasingly positive, particularly for programs with stronger financial incentives. A systematic review published in Health Affairs analyzed 24 unique value-based purchasing programs and found that higher-intensity programs, those with larger financial stakes and more comprehensive quality requirements, were more frequently associated with quality improvement and spending reductions than lower-intensity ones.
The pattern held across multiple types of outcomes. Among high-intensity programs, seven out of eight showed positive or mixed-positive effects on spending reduction, compared to just six of fourteen lower-intensity programs. For quality measures related to how care is actually used (like avoiding unnecessary hospitalizations), six of eight high-intensity programs showed improvement versus five of nine lower-intensity ones. The takeaway: the strength of the financial incentive matters. Programs that ask providers to put more skin in the game tend to produce better results.
Not every program succeeds, though. At least one lower-intensity program was associated with increased spending rather than savings. And the research consistently shows that modest bonuses layered on top of fee-for-service payments often produce little measurable change.
A New Health Equity Adjustment
One longstanding criticism of value-based purchasing is that hospitals serving poorer, sicker populations are disadvantaged. These hospitals tend to have higher complication rates and lower patient experience scores, not necessarily because of worse care, but because their patients face more barriers to health. A hospital in a low-income neighborhood treats patients who may lack transportation, stable housing, or access to follow-up care, all of which affect outcomes the hospital is measured on.
CMS is addressing this beginning in fiscal year 2026 with a health equity adjustment. Hospitals that serve a higher proportion of patients dually eligible for both Medicare and Medicaid (a proxy for low income) and that deliver high-quality care will be eligible for up to 10 additional points on their Total Performance Score. This expands the scoring range from 0 to 100 to 0 to 110, giving safety-net hospitals a meaningful opportunity to be rewarded rather than penalized for the populations they serve.
Challenges for Rural and Small Facilities
Value-based purchasing assumes a set of conditions that many rural and smaller healthcare facilities simply don’t have. The model works best when providers have large patient panels (making quality statistics reliable), robust data systems (to track and report outcomes), and enough financial cushion to invest in care coordination, population health tools, and quality improvement infrastructure. Rural practices often lack all three.
Small patient volumes create a statistical problem: a handful of bad outcomes can swing a quality score dramatically, making performance measures unreliable. Limited IT infrastructure means many rural clinics struggle to collect, analyze, and report the data these programs require, and they often can’t afford the specialized vendors needed to pull information from their electronic health records. Rural provider organizations also tend to operate on extremely thin financial margins, making it risky to invest in new staffing or technology without guaranteed returns.
There’s also a workforce challenge. Value-based care often relies on care coordinators, behavioral health specialists, and data analysts. Recruiting these professionals to rural areas is difficult. Federally qualified health centers, which serve many rural and underserved communities, are particularly cautious about any payment change that might compromise the stable per-visit rates they currently depend on for survival.
These barriers don’t mean value-based purchasing can’t work in rural settings, but they do mean that a one-size-fits-all approach risks widening the gap between well-resourced urban health systems and the smaller facilities that serve some of the country’s most vulnerable populations.